$The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis$

The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis

Molica, Stefano; Giannarelli, Diana; Mirabelli, Rosanna; Levato, Luciano; Shanafelt, Tait D.

期刊名称Leukemia & Lymphoma
作者Molica, Stefano; Giannarelli, Diana; Mirabelli, Rosanna; Levato, Luciano; Shanafelt, Tait D.
印刷ISSN1042-8194
电子ISSN1029-2403
文件大小991.74KB
发表时间2018-12-05
DOI10.1080/10428194.2018.1543882
页码1-6

发现好书期刊，享受阅读乐趣

The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis